The page is the record's research on the issuer — no analyst, no rating, no view.

Monte Rosa Therapeutics, Inc. (GLUE) — research page

US · us-cm-kg/NASDAQ/GLUE · as of 2026-11-08

Identity and listing

The issuer is Monte Rosa Therapeutics, Inc., listed on NASDAQ under ticker GLUE, with ISIN US61225M1027. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The segment is not on the record. The issuer is listed and not halted.

fieldvaluesource · read date
nameMonte Rosa Therapeutics, Inc.source · 2026-11-08
exchangeNASDAQsource · 2026-11-08
tickerGLUEsource · 2026-11-08
ISINUS61225M1027source · 2026-10-02
LEInot on the record
security typeCorporatesource · 2026-11-08
segmentnot on the record
sector2836 Biological Products, (No Diagnostic Substances)source · 2026-11-08
jurisdictionUnited States — Delawaresource · 2026-11-08
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 110 filings in the twelve months to 2026-11-08, across 63 filing days. The median gap between filing days is 2.0 days. The latest filing is dated 2026-11-05, three days before the record date, and is of type results. The NASDAQ median cadence gap is 6.0 days, the NASDAQ median filings count is 52, and the NASDAQ median latency is 5.0 days. The sector median cadence gap is 5.5 days, the sector median filings count is 65.5, and the sector median latency is 4.0 days. By type, the window holds 48 regulatory filings, 41 directors' dealings, 8 results, 6 corporate news, 3 prospectuses, 3 AGM/EGM filings, and 1 director change.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer11023
exchange median: NASDAQ (4359 issuers)5265
sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers)65.55.54
datetypecategoryfiling
2026-11-05results10-Q10-Q — 10-Q
2026-11-05results8-K8-K — 8-K (items 2.02,9.01)
2026-10-06directors_dealings44 — 4
2026-10-01corporate_news8-K8-K — 8-K (items 7.01,8.01,9.01)
2026-09-08corporate_news8-K8-K — 8-K (items 7.01,8.01,9.01)

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover, as foreign private issuers and older filings carry none). The auditor location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted.

Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

Open research

No openly published research notes were found. The count is 0.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. The market's vintage is sealed.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
10.2
https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
10.3
https://data.sec.gov/submissions/CIK0001826457.json (identity.jurisdiction)
10.4
https://mcp.us-cm-kg.ai/events/NASDAQ/GLUE (the disclosure lines)
10.5
https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
10.6
https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://mcp.us-cm-kg.ai/record/NASDAQ/GLUE (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US61225M1027"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:31704e77e36378cb.